Kombucha's effects on emotional distress and sleep in breast cancer survivors
Effects of Kombucha Intervention on Emotional Distress and Sleep Quality in Breast Cancer Survivors
This study is testing whether drinking kombucha can help breast cancer survivors feel less emotional distress and improve their sleep quality.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | All |
| Sponsor | National Yang Ming Chiao Tung University Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05717972 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of kombucha consumption on emotional distress and sleep quality among breast cancer survivors. Participants will include individuals who have completed their cancer treatment and are experiencing emotional and sleep-related challenges. The intervention involves regular intake of kombucha, with the aim of assessing its potential benefits on mental health and sleep patterns. The study will follow a structured protocol to ensure adherence and accurate data collection.
Who should consider this trial
Good fit: Ideal candidates are breast cancer survivors at stages 0-III who are experiencing emotional distress and poor sleep quality.
Not a fit: Patients with stage IV breast cancer or those with significant underlying health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could improve emotional well-being and sleep quality for breast cancer survivors.
How similar studies have performed: While the specific use of kombucha in this context is novel, other studies have explored dietary interventions for emotional and sleep-related issues with varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stage 0-III Breast Cancer * No any cancer treatment in the following year * Perceived emotional distress and poor sleep quality * Agree to follow the protocol of this study Exclusion Criteria: * Stage IV Breast Cancer * Pregnant women * Abnormal liver, kidney, gastric, internal , immune, sleep disorder, metabolic, psychic functions and need to take the prescription medications or medical treatments regularly * could not follow the protocol of this study
Where this trial is running
Taipei
- National Yang-Ming University — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: I-Ching Hou, PhD — National Yang Ming Chiao Tung University
- Study coordinator: I-Ching Hou, PhD
- Email: evidta@gmail.com
- Phone: 886-2-28267000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.